Galiz Research

Phase 3 Trial of Flutemetamol Labeled With Radioactive Fluorine 18 Imaging and Neuritic Plaque Density

Craig Curtis, José E. Gámez, Upinder Singh et al. · JAMA Neurology · 2015 · 337 citations · Full text

Medicine, Neurology, Nuclear Medicine +17

A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study

Merçé Boada, Oscar L. López, Javier Olazarán et al. · Alzheimer s & Dementia · 2020 · 132 citations · Full text

Medicine, Geriatric Medicine, Neurology +13

Performance of [¹⁸F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA‐AA recommendations for the neuropathologic diagnosis of Alzheimer's disease

Stephen Salloway, José E. Gámez, Upinder Singh et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2017 · 92 citations · Full text

Medicine, Neurology, Pathology +17

Use of Flutemetamol F 18–Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment

David A. Wolk, Carl Sadowsky, Beth Safirstein et al. · JAMA Neurology · 2018 · 87 citations · Full text

Medicine, Neurology, Neuroscience +17

Neuropsychological, neuropsychiatric, and quality‐of‐life assessments in Alzheimer's disease patients treated with plasma exchange with albumin replacement from the randomized AMBAR study

Merçé Boada, Oscar L. López, Javier Olazarán et al. · Alzheimer s & Dementia · 2021 · 35 citations · Full text

Medicine, Geriatric Medicine, Neurology +17